State Street Corp Kiniksa Pharmaceuticals, Ltd. Transaction History

State Street Corp

  • $2.21 Trillion
  • Q1 2024

A detailed history of State Street Corp transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, State Street Corp holds 1,888,544 shares of KNSA stock, worth $36.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,888,544
Previous 1,546,096 22.15%
Holding current value
$36.1 Million
Previous $27.1 Million 37.4%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.63 - $21.74 $6.04 Million - $7.44 Million
342,448 Added 22.15%
1,888,544 $37.3 Million
Q4 2023

Feb 14, 2024
SELL
$14.37 - $19.07 $3.1 Million - $4.11 Million
-215,576 Reduced 12.24%
1,546,096 $27.1 Million
Q3 2023

Nov 14, 2023
BUY
$13.62 - $20.2 $1.49 Million - $2.22 Million
109,701 Added 6.64%
1,761,672 $30.6 Million
Q2 2023

Aug 14, 2023
SELL
$10.44 - $16.48 $1.52 Million - $2.4 Million
-145,473 Reduced 8.09%
1,651,971 $23.3 Million
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $3.29 Million - $4.85 Million
307,333 Added 20.62%
1,797,444 $19.3 Million
Q4 2022

Feb 14, 2023
BUY
$11.42 - $17.05 $10 Million - $15 Million
878,769 Added 143.74%
1,490,111 $22.3 Million
Q3 2022

Nov 15, 2022
BUY
$9.76 - $13.41 $258,747 - $355,512
26,511 Added 4.53%
611,342 $7.85 Million
Q2 2022

Aug 15, 2022
BUY
$7.6 - $11.41 $134,466 - $201,877
17,693 Added 3.12%
584,831 $5.67 Million
Q1 2022

May 16, 2022
SELL
$9.3 - $12.37 $8.35 Million - $11.1 Million
-898,033 Reduced 61.29%
567,138 $5.64 Million
Q4 2021

Feb 14, 2022
SELL
$10.39 - $15.15 $5.91 Million - $8.62 Million
-568,911 Reduced 27.97%
1,465,171 $17.2 Million
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $2.97 Million - $4.23 Million
-260,622 Reduced 11.36%
2,034,082 $23.2 Million
Q2 2021

Aug 16, 2021
BUY
$13.22 - $19.09 $11.6 Million - $16.8 Million
879,922 Added 62.19%
2,294,704 $32 Million
Q1 2021

May 17, 2021
SELL
$16.68 - $23.97 $2.73 Million - $3.92 Million
-163,730 Reduced 10.37%
1,414,782 $26.2 Million
Q4 2020

Feb 16, 2021
BUY
$14.8 - $21.15 $17.2 Million - $24.6 Million
1,164,059 Added 280.87%
1,578,512 $27.9 Million
Q3 2020

Nov 10, 2020
BUY
$15.21 - $25.53 $1.38 Million - $2.31 Million
90,573 Added 27.96%
414,453 $6.35 Million
Q2 2020

Aug 14, 2020
BUY
$15.08 - $26.0 $1.52 Million - $2.62 Million
100,650 Added 45.09%
323,880 $8.25 Million
Q1 2020

May 11, 2020
BUY
$11.0 - $19.76 $2.46 Million - $4.41 Million
223,230 New
223,230 $3.46 Million

Others Institutions Holding KNSA

# of Institutions
164
Shares Held
40.6M
Call Options Held
186K
Put Options Held
157K
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $658M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email